Literature DB >> 18612200

Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation.

Hideki Fujii1, Akira Fukuda, Motoko Tanaka, Yoko Kojima, Tatsuro Ishida, Ken-Ichi Hirata, Masafumi Fukagawa.   

Abstract

BACKGROUND/AIMS: A recent study suggests that inflammation and malnutrition are strongly associated with cardiovascular disease in dialysis patients. Endothelial lipase (EL) is a newly cloned physiological regulator of high-density lipoprotein cholesterol (HDL), which is associated with the progression of atherosclerosis. To clarify the role of EL in dialysis patients, we evaluated serum markers on the basis of the presence of hypoalbuminemia and inflammation.
METHODS: We divided the 97 study patients into two groups on the basis of serum albumin (Alb) and high-sensitive C-reactive protein (hsCRP) levels, and measured serum EL levels. Serum EL levels were significantly correlated with Alb, cholinesterase, log hsCRP, and log tumor necrosis factor-alpha. They were also assigned to one of three groups on the basis of hypoalbuminemia and inflammatory status.
RESULTS: Serum EL levels were significantly higher and serum HDL levels were lower in patients with low serum Alb and/or high hsCRP levels than in those without these abnormalities. Furthermore, when patients were classified into two groups on the basis of the EL levels measured, cardiovascular disease events during the 2-year follow-up period were significantly greater in the group with higher EL levels.
CONCLUSIONS: Our findings suggest that the link between EL, hypoalbuminemia and inflammation may play an important role in atherogenesis in dialysis patients. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612200     DOI: 10.1159/000144025

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  5 in total

1.  Endothelial lipase is localized to follicular epithelial cells in the thyroid gland and is moderately expressed in adipocytes.

Authors:  Margery A Connelly; Michael R D'Andrea; Jenson Qi; Keli C Dzordzorme; Bruce P Damiano
Journal:  J Histochem Cytochem       Date:  2012-06-26       Impact factor: 2.479

Review 2.  Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport.

Authors:  Wijtske Annema; Uwe J F Tietge
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

3.  Increased expression of endothelial lipase in symptomatic and unstable carotid plaques.

Authors:  Matias Trbušić; Monika Riederer; Majda Vučić; Ivo Lovričević; Božo Krušlin; Martin Gauster; Sonja Mohrenz; Andrea Berghold; Beate Tiran; Vesna Degoricija; Saša Frank
Journal:  J Neurol       Date:  2011-08-13       Impact factor: 4.849

4.  Endothelial Lipase Plasma Levels are Increased in Patients With Significant Carotid Artery Stenosis and History of Neurological Impairment.

Authors:  Monika Riederer; Matias Trbušić; Vesna Degoricija; Saša Frank
Journal:  J Clin Med Res       Date:  2012-01-17

5.  Metabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients.

Authors:  Ines Potočnjak; Matias Trbušić; Sanda Dokoza Terešak; Bojana Radulović; Gudrun Pregartner; Andrea Berghold; Beate Tiran; Gunther Marsche; Vesna Degoricija; Saša Frank
Journal:  Sci Rep       Date:  2017-04-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.